bluebird bio Updates Plans for the Year Ahead – Fox Business
Reurope |
bluebird bio Updates Plans for the Year Ahead
Fox Business At the American Society of Hematology (ASH) Annual Meeting in December, Bluebird presented promising data for its updated manufacturing process for LentiGlobin, its gene therapy for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease … Bluebird Bio, Inc. – BLUE – Stock Price Today – Zacks X0306 4 2018-02-01 0 0001293971 bluebird bio, Inc. BLUE 0001578696 Davidson David C/O BLUEBIRD BIO, INC. 60 … |
